BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Impact of Race/Ethnicity on Platelet Function

Completed

Conditions: Coronary Heart Disease

First Posted Date: 2010-07-23

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 625

Registration Number: NCT01168622

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Maximizing Outcomes Needed After Percutaneous Coronary Intervention (PCI) Using Weight Management (MOMENTUM)

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: MOMENTUM

First Posted Date: 2010-07-16

Last Posted Date: 2023-09-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 50

Registration Number: NCT01163968

Locations: 🇺🇸
BryanLGH Medical Center, Lincoln, Nebraska, United States

Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis

Completed

Conditions: Rheumatoid Arthritis
Osteoarthritis
Periodontal Disease

Interventions: Radiation: Digital xray of jaw and teeth
Procedure: Blood draw
Other: questionnaires
Procedure: Periodontal Examination
Other: Bilateral digital xray of hands

First Posted Date: 2010-07-02

Last Posted Date: 2023-11-02

Lead Sponsor: University of Nebraska

Target Recruit Count: 617

Registration Number: NCT01156155

Locations: 🇺🇸
Veterans Affairs Medical Center, Omaha, Omaha, Nebraska, United States

Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery

Phase 1

Completed

Conditions: Ileus

Interventions: Drug: stool softener
Dietary Supplement: sugar free gum

First Posted Date: 2010-07-02

Last Posted Date: 2023-09-07

Lead Sponsor: University of Nebraska

Target Recruit Count: 111

Registration Number: NCT01156129

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

Herbal Lollipops on Oral Bacterial Levels and DMFT/Dmft Scores of Children With Asthma Using Inhalers

Not Applicable

Terminated

Conditions: Asthma
Dental Caries

Interventions: Dietary Supplement: Chinese Licorice Root

First Posted Date: 2010-06-22

Last Posted Date: 2023-08-23

Lead Sponsor: University of Nebraska

Target Recruit Count: 39

Registration Number: NCT01147835

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Aqueous Humor Dynamics and Brimonidine

Early Phase 1

Completed

Conditions: Intraocular Pressure

Interventions: Drug: Brimonidine
Drug: Artificial tears

First Posted Date: 2010-06-15

Last Posted Date: 2023-11-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 35

Registration Number: NCT01144494

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery

Phase 2

Completed

Conditions: Stage IA Breast Cancer
Stage IB Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer

Interventions: Drug: cyclophosphamide
Drug: paclitaxel
Biological: trastuzumab
Other: laboratory biomarker analysis

First Posted Date: 2010-04-20

Last Posted Date: 2023-09-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 112

Registration Number: NCT01106898

Locations: 🇺🇸
Saint Francis Medical Center, Grand Island, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer

Phase 1

Terminated

Conditions: Recurrent Prostate Cancer
Adenocarcinoma of the Prostate
Hormone-resistant Prostate Cancer

Interventions: Drug: lenalidomide
Drug: cyclophosphamide
Other: laboratory biomarker analysis
Other: questionnaire administration
Other: quality-of-life assessment

First Posted Date: 2010-03-25

Last Posted Date: 2023-09-13

Lead Sponsor: University of Nebraska

Target Recruit Count: 25

Registration Number: NCT01093183

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Phase 1

Completed

Conditions: Adenocarcinoma of the Pancreas
Stage III Pancreatic Cancer

Interventions: Drug: gemcitabine hydrochloride
Drug: leucovorin calcium
Drug: fluorouracil
Drug: nelfinavir mesylate
Radiation: stereotactic body radiation therapy
Radiation: hypofractionated radiation therapy
Procedure: therapeutic conventional surgery

First Posted Date: 2010-02-12

Last Posted Date: 2023-10-10

Lead Sponsor: University of Nebraska

Target Recruit Count: 46

Registration Number: NCT01068327

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 1

Completed

Conditions: Non-Hodgkin's Lymphoma

Interventions: Drug: Lenalidomide
Drug: ofatumumab

First Posted Date: 2010-02-02

Last Posted Date: 2023-10-04

Lead Sponsor: University of Nebraska

Target Recruit Count: 46

Registration Number: NCT01060384

Locations: 🇺🇸
Saint Francis Medical Center, Grand Island, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy